 Fluidigm NASDAQ:FLDM was downgraded by Zacks Investment Research from a hold rating to a sell rating in a research report issued on Monday, Zacks.com reports. According to Zacks, Fluidigm Corporation operates as a biotech tools company that creates microfluidic-based chips and instrumentation for biological research. Products offered by the Company include BioMark HD System- a ... 